Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 3
2009 1
2010 3
2011 2
2012 2
2013 1
2014 1
2015 1
2016 1
2017 3
2018 8
2019 2
2020 4
2021 8
2022 7
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Vaccine Development for Cytomegalovirus.
Inoue N, Abe M, Kobayashi R, Yamada S. Inoue N, et al. Among authors: yamada s. Adv Exp Med Biol. 2018;1045:271-296. doi: 10.1007/978-981-10-7230-7_13. Adv Exp Med Biol. 2018. PMID: 29896672 Review.
[Varicella-zoster virus (VZV)].
Kanai K, Yamada S, Inoue N. Kanai K, et al. Among authors: yamada s. Uirusu. 2010 Dec;60(2):197-207. doi: 10.2222/jsv.60.197. Uirusu. 2010. PMID: 21488333 Free article. Review. Japanese.
Varicella Vaccine-Induced Infantile Zoster-Like Skin Rash.
Sugai T, Fujita Y, Yamada S, Fukushi S, Inamura E, Hatakeyama K, Shimizu S. Sugai T, et al. Among authors: yamada s. J Pediatr. 2022 Dec;251:218-219. doi: 10.1016/j.jpeds.2022.08.032. Epub 2022 Aug 23. J Pediatr. 2022. PMID: 36027973 No abstract available.
Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters.
Shiwa-Sudo N, Sakai Y, Iwata-Yoshikawa N, Watanabe S, Yamada S, Kuroda Y, Yamamoto T, Shirakura M, Fujisaki S, Miyazaki K, Miura H, Nagata S, Fukushi S, Maeda K, Hasegawa H, Suzuki T, Nagata N. Shiwa-Sudo N, et al. Among authors: yamada s. J Virol. 2023 Jan 31;97(1):e0136622. doi: 10.1128/jvi.01366-22. Epub 2023 Jan 12. J Virol. 2023. PMID: 36633406 Free PMC article.
Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2.
Ohashi H, Hishiki T, Akazawa D, Kim KS, Woo J, Shionoya K, Tsuchimoto K, Iwanami S, Moriyama S, Kinoshita H, Yamada S, Kuroda Y, Yamamoto T, Kishida N, Watanabe S, Hasegawa H, Ebihara H, Suzuki T, Maeda K, Fukushi S, Takahashi Y, Iwami S, Watashi K. Ohashi H, et al. Among authors: yamada s. Antiviral Res. 2022 Sep;205:105372. doi: 10.1016/j.antiviral.2022.105372. Epub 2022 Jul 4. Antiviral Res. 2022. PMID: 35798223 Free PMC article.
Development of an RT-LAMP Assay for the Rapid Detection of SFTS Virus.
Sano S, Fukushi S, Yamada S, Harada S, Kinoshita H, Sugimoto S, Yoshikawa T, Kurosu T, Takamatsu Y, Shimojima M, Toda S, Hamada Y, Fujisawa N, Sugimoto T, Saijo M. Sano S, et al. Among authors: yamada s. Viruses. 2021 Apr 16;13(4):693. doi: 10.3390/v13040693. Viruses. 2021. PMID: 33923720 Free PMC article.
Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants.
Miyamoto S, Arashiro T, Adachi Y, Moriyama S, Kinoshita H, Kanno T, Saito S, Katano H, Iida S, Ainai A, Kotaki R, Yamada S, Kuroda Y, Yamamoto T, Ishijima K, Park ES, Inoue Y, Kaku Y, Tobiume M, Iwata-Yoshikawa N, Shiwa-Sudo N, Tokunaga K, Ozono S, Hemmi T, Ueno A, Kishida N, Watanabe S, Nojima K, Seki Y, Mizukami T, Hasegawa H, Ebihara H, Maeda K, Fukushi S, Takahashi Y, Suzuki T. Miyamoto S, et al. Among authors: yamada s. Med. 2022 Apr 8;3(4):249-261.e4. doi: 10.1016/j.medj.2022.02.006. Epub 2022 Mar 4. Med. 2022. PMID: 35261995 Free PMC article.
Non-Omicron breakthrough infection with higher viral load and longer vaccination-infection interval improves SARS-CoV-2 BA.4/5 neutralization.
Miyamoto S, Arashiro T, Ueno A, Kanno T, Saito S, Katano H, Iida S, Ainai A, Ozono S, Hemmi T, Hirata Y, Moriyama S, Kotaki R, Kinoshita H, Yamada S, Shinkai M, Fukushi S, Takahashi Y, Suzuki T. Miyamoto S, et al. Among authors: yamada s. iScience. 2023 Feb 17;26(2):105969. doi: 10.1016/j.isci.2023.105969. Epub 2023 Jan 13. iScience. 2023. PMID: 36687316 Free PMC article.
Varicella pneumonia in an immunocompetent, unvaccinated man: A case report.
Okumura N, Ishikane M, Fukushi S, Yamada S, Ochi W, Iwamoto N, Yamamoto K, Ujiie M, Ohmagari N. Okumura N, et al. Among authors: yamada s. IJID Reg. 2021 Dec 6;2:60-62. doi: 10.1016/j.ijregi.2021.11.013. eCollection 2022 Mar. IJID Reg. 2021. PMID: 35757075 Free PMC article.
Macacine alphaherpesvirus 1 (B Virus) Infection in Humans, Japan, 2019.
Yamada S, Katano H, Sato Y, Suzuki T, Uda A, Ishijima K, Suzuki M, Yamada D, Harada S, Kinoshita H, Nguyen PHA, Ebihara H, Maeda K, Saijo M, Fukushi S. Yamada S, et al. Emerg Infect Dis. 2024 Jan;30(1):177-179. doi: 10.3201/eid3001.230435. Epub 2023 Dec 12. Emerg Infect Dis. 2024. PMID: 38086399 Free PMC article.
52 results